PharmaCyte Biotech, Inc. - Common Stock (PMCB)
1.2100
+0.4300 (55.13%)
NASDAQ · Last Trade: Dec 4th, 7:12 PM EST
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · December 4, 2025
Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.
Via Chartmill · December 4, 2025
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · December 4, 2025

PharmaCyte Biotech just reported results for the third quarter of 2024.
Via InvestorPlace · March 19, 2024
The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Via Chartmill · December 4, 2025
After the closing bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via Chartmill · November 25, 2025
PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.
Via Stocktwits · November 25, 2025
Via Benzinga · August 19, 2025
Via Benzinga · May 27, 2025

PharmaCyte Biotech just reported results for the second quarter of 2024.
Via InvestorPlace · December 18, 2023

Via Benzinga · May 11, 2023

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.
Via Benzinga · April 22, 2022

Gainers
Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
Via Benzinga · April 19, 2022

On Tuesday, 386 stocks made new 52-week lows.
Via Benzinga · September 26, 2023

PharmaCyte Biotech Inc (NASDAQ: PMCB) updated its activities to lift the FDA's clinical hold on PharmaCyte's treatment for locally advanced, inoperable...
Via Benzinga · February 14, 2022

Gainers
Epizyme (NASDAQ:EPZM) shares incr...
Via Benzinga · February 1, 2022

Upgrades
For Nektar Therapeutics (NASDAQ:
Via Benzinga · November 8, 2021

Gainers
Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via Benzinga · October 28, 2021

Gainers
Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via Benzinga · October 27, 2021

Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
Via Benzinga · October 27, 2021

PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate.
These...
Via Benzinga · September 16, 2021

Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...
Via Benzinga · September 10, 2021

Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...
Via Benzinga · September 13, 2021

The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today.
Investors are expecting a major announcement from the company...
Via Benzinga · September 9, 2021

Gainers
Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million.
Cardiff...
Via Benzinga · September 9, 2021
